Invasive candidiasis

Area of Science:

• Infectious Diseases
• Clinical Microbiology
• Hospital Epidemiology

Background:

• Invasive candidiasis (IC) is a significant nosocomial infection with persistent diagnostic and therapeutic hurdles.
• Epidemiological shifts in IC are influenced by increased use of antifungal prophylaxis, broad-spectrum antibiotics, and indwelling medical devices.
• Current diagnostic methods for IC often lack sensitivity, delaying critical early interventions.

Purpose of the Study:

• To highlight the unmet needs in the diagnosis and management of invasive candidiasis.
• To emphasize the necessity for enhanced diagnostic tools for earlier detection of IC.
• To call for further research into optimal treatment strategies for candidemia and non-albicans Candida infections.

Main Methods:

• Review of current literature on invasive candidiasis epidemiology, diagnostics, and therapeutics.
• Analysis of challenges in clinical practice related to patient risk stratification and prevention.
• Identification of research gaps in understanding and managing IC.

Main Results:

• Diagnosis of IC remains challenging, necessitating improved tools for timely intervention.
• Emerging antifungal agents show promise, but their optimal use, particularly for non-albicans species, requires further investigation.
• Lack of a consistent approach to treatment and prevention for high-risk individuals persists despite known risk factors and mortality.

Conclusions:

• There is a critical need for advanced diagnostic modalities to facilitate earlier diagnosis and treatment of invasive candidiasis.
• Further research is essential to optimize the use of newer antifungal agents and develop standardized prevention strategies for high-risk populations.
• Addressing these clinical research areas is vital for improving the management of this common and evolving nosocomial infection.